Literature DB >> 32008742

Lipin-2 degradation elicits a proinflammatory gene signature in macrophages.

Asami Watahiki1, Kouhei Shimizu2, Seira Hoshikawa3, Mitsuki Chiba1, Hiroshi Kitamura4, Hiroshi Egusa1, Satoshi Fukumoto5, Hiroyuki Inuzuka6.   

Abstract

Lipin-2 is a phosphatidate phosphatase with key roles in regulating lipid storage and energy homeostasis. LPIN2-genetic deficiency is associated with an autoinflammatory disorder, underscoring its critical role in innate immune signaling; however, the regulatory mechanisms underlying protein stability remain unknown. Here, we demonstrate that Lipin-2 interacts with β-TRCP, a substrate receptor subunit of the SCFβ-TRCP E3 ligase, and undergoes ubiquitination and proteasomal degradation. β-TRCP-knockout in RAW264.7 macrophages resulted in Lipin-2 accumulation, leading to the suppression of LPS-induced MAPK activation and subsequent proinflammatory gene expression. Consistent with this, treatment with MLN4924, a Cullin-neddylation inhibitor that suppresses SCF E3 activity, increased Lipin-2 protein and concomitantly decreased Il1b expression. These findings suggested that β-TRCP-mediated Lipin-2 degradation affects macrophage-elicited proinflammatory responses and could lead to new therapeutic approaches to treat inflammatory diseases.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-1β; Inflammation; Lipin-2; MLN4924; Ubiquitination; β-TRCP

Mesh:

Substances:

Year:  2020        PMID: 32008742     DOI: 10.1016/j.bbrc.2020.01.119

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Association Between Neddylation and Immune Response.

Authors:  Jiali Zhu; Feng Chu; Meirong Zhang; Wenhuan Sun; Fangfang Zhou
Journal:  Front Cell Dev Biol       Date:  2022-05-05

2.  Deficiency of Lipin2 Results in Enhanced NF-κB Signaling and Osteoclast Formation in RAW-D Murine Macrophages.

Authors:  Asami Watahiki; Seira Hoshikawa; Mitsuki Chiba; Hiroshi Egusa; Satoshi Fukumoto; Hiroyuki Inuzuka
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.